咽鼓管球囊扩张联合鼻腔雾化治疗成人分泌性中耳炎疗效研究

doi:10.3760/cma.j.cn441417-20250121-14018

摘要/Abstract

摘要：

目的　分析咽鼓管球囊扩张技术联合压力雾化鼻腔疗法在成人分泌性中耳炎治疗中的临床效果。方法　采用前瞻性研究，选取2020年1月至2023年1月在陕西省人民医院接受诊疗的102例成人分泌性中耳炎患者，通过随机数字表法分为参照组（采用咽鼓管球囊扩张术治疗）和联合组（在参照组基础上联合压力雾化鼻腔治疗）。联合组51例，男29例、女22例，年龄（38.26±5.16）岁，病程（4.36±0.47）年；21例左侧，30例右侧；参照组51例，男27例、女24例，年龄（39.87±4.97）岁，病程（4.42±0.51）年；23例左侧，28例右侧。比较两组患者的临床疗效、听力功能、咽鼓管功能相关指标［咽鼓管功能评分量表（ETS-5）与七项咽鼓管功能障碍症状评分量表（ETDQ-7）］、生活质量［中文版慢性耳病调查量表（CCES）］及不良反应和复发率。采用t检验、χ²检验进行统计分析。结果　联合组的总有效率为96.08%（49/51），高于参照组的82.35%（42/51），差异有统计学意义（P<0.05）。治疗后，联合组患者的气导听阈、骨导听阈、气骨导差均低于参照组（均P<0.05）；联合组患者的ETS-5评分以及CCES各项评分高于参照组，ETDQ-7评分低于参照组（均P<0.05）。联合组的不良事件发生率与参照组比较，差异无统计学意义（P>0.05）。联合组的复发率低于参照组［1.96%（1/51）比15.69%（8/51）］，差异有统计学意义（P<0.05）。结论　咽鼓管扩张技术联合鼻腔压力雾化疗法在成人分泌性中耳炎的治疗中展现出显著优势，治疗安全性高。

关键词: 分泌性中耳炎, 咽鼓管球囊扩张术, 压力雾化鼻腔治疗, 听力功能, 生活质量

Abstract:

Objective　To investigate the clinical efficacy of balloon dilation eustachian tuboplasty combined with nasal nebulization in the treatment of adults with secretory otitis media. Methods　A prospective study was conducted on 102 adult patients with secretory otitis media treated at Shaanxi Provincial People's Hospital from January 2020 to January 2023. They were divided into a reference group, treated with balloon dilation eustachian tuboplasty, and a combined group, treated with balloon dilation eustachian tuboplasty and pressurized nasal nebulization, by the random number table method, with 51 cases in each group. The combined group consisted of 29 males and 22 females; they were (38.26±5.16) years old; their disease duration was (4.36±0.47) years; affected sides: 21 left and 30 right. The reference group consisted of 27 males and 24 females; they were (39.87±4.97) years old; their disease duration was (4.42±0.51) years; affected sides: 23 left and 28 right. The clinical efficacies, hearing function, Eustachian tube function [Eustachian Tube Score-5 (ETS-5) and Eustachian Tube Dysfunction Questionnaire-7 (ETDQ-7)], quality of life [Chinese version of the Chronic Ear Survey (CCES)], adverse events, and recurrence rates were compared between the two groups. Statistical analyses were performed using t tests and χ² tests. Results　The overall efficacy rate in the combined group was higher than that in the reference group [96.08% (49/51) vs. 82.35% (42/51)], with a statistical difference (P<0.05). After the treatment, the air conduction threshold, bone conduction threshold, and air-bone gap in the combined group were lower than those in the reference group (all P<0.05); The scores of ETS-5 and CCES in the combined group were higher than those in the reference group, while the score of ETDQ-7 was lower (all P<0.05). There was no statistical difference in the incidence rate of adverse events between the two groups (P>0.05). The recurrence rate of combined group was lower than that of the reference group [1.96% (1/51) vs. 15.69% (8/51)], with a statistical difference (P<0.05). Conclusion　Balloon dilation eustachian tuboplasty combined with nasal nebulization in the treatment of adults with secretory otitis media is effective and safe.

Key words: Secretory otitis media, , Balloon dilation eustachian tuboplasty, , Pressurized nasal nebulization, , Hearing function, , Quality of life

李世东杨启梅贠勇刚.

咽鼓管球囊扩张联合鼻腔雾化治疗成人分泌性中耳炎疗效研究 [J]. 国际医药卫生导报, 2025, 31(14): 2378-2382.

Li Shidong, Yang Qimei, Yun Yonggang.

Efficacy of balloon dilation eustachian tuboplasty combined with nasal nebulization in treatment of adults with secretory otitis media [J]. International Medicine and Health Guidance News, 2025, 31(14): 2378-2382.

参考文献

[1]黄海林,尤慧华.不同浓度地塞米松鼓室注射治疗分泌性中耳炎疗效探讨[J].中国耳鼻咽喉头颈外科, 2024, 31(11): 738-741. DOI:10.16066/j.1672-7002.2024.11.013.

[2]Cebi IT, Bayram O, Gocgun N, et al. Evaluation of Eustachian tube dimensions by temporal bone computed tomography in patients with chronic otitis media[J]. J Laryngol Otol, 2024, 138(2): 130-135. DOI: https://doi.org/10.1017/S0022215123001469

[3]葛亮,朱顺芳.咽鼓管球囊扩张术联合鼓膜置管术治疗慢性分泌性中耳炎疗效分析[J].皖南医学院学报, 2024, 43(3): 226-228,233. DOI:10.3969/j.issn.1002-0217.2024.03.006.

[4]杨静,陈默,王梓敬,等.咽鼓管压力雾化吹张治疗成年人急性分泌性中耳炎的临床疗效评估[J].中国耳鼻咽喉头颈外科, 2024, 31(9): 565-568. DOI:10.16066/j.1672-7002.2024.09.005.

[5]中华医学会耳鼻咽喉头颈外科学分会耳科学组,中华耳鼻咽喉头颈外科杂志编辑委员会耳科组.中耳炎临床分类和手术分型指南(2012)[J].中华耳鼻咽喉头颈外科杂志, 2013, 48(1): 5. DOI:10.3760/cma.j.issn.1673-0860.2013.01.003.

[6]蒋劲松,黄辉,何苗,等.耳内镜下鼓室成形术对慢性中耳炎伴有鼓膜穿孔患者听力水平的影响[J].临床和实验医学杂志, 2022, 21(17): 1873-1876. DOI:10.3969/j.issn.1671-4695.2022.17.022.

[7]Chen X, Tong MCF, Chang WT. A nomogram diagnostic model for eustachian tube dysfunction in patients with tympanic membrane perforation[J]. J Otolaryngol Head Neck Surg, 2024, 53: 19160216241293068. DOI: 10.1177/19160216241293068.

[8]McCoul E D, Anand V K, Christos P J. Validating the clinical assessment of eustachian tube dysfunction: the Eustachian Tube Dysfunction Questionnaire (ETDQ‐7)[J]. Laryngoscope, 2012, 122(5): 1137-1141. DOI: 10.1002/lary.23223

[9]袁毅方,余艳,吴革平,等.不同显微技术下经外耳道入路鼓室成形术治疗慢性中耳炎的临床研究[J].临床和实验医学杂志, 2024, 23(20): 2215-2219. DOI:10.3969/j.issn.1671-4695.2024.20.023.

[10]Yin X, Liu L, Luo M, et al. Association between secretory otitis media and laryngopharygeal reflux in adults[J]. Acta Oto-Laryngologica, 2023, 143(11-12): 946-950. DOI: 10.1080/00016489.2024.2302317.

[11]Liu W, Shi L, Feng Y. Advance in the pathogenesis of otitis media with effusion induced by platelet-activating factor[J]. Science Progress, 2024,107(4): 00368504241265171. DOI 10.1177/00368504241265171.

[12]Guo C, Pan L, Chen L, et al. Investigating the epidemiological relevance of secretory otitis media and neighboring organ diseases through an Internet search[J]. PeerJ, 2024, 12: e16981. DOI: 10.7717/peerj.16981.

[13]张倩,田家旺,李凌伟,等.慢性化脓性中耳炎患者咽鼓管功能检测和结果分析[J].中华耳科学杂志, 2024, 22(5): 760-764. DOI:10.3969/j.issn.1672-2922.2024.05.013.

[14]谢先荣,付亚峰,刘伟清.经鼓室口咽鼓管球囊扩张术的疗效及咽鼓管功能的影响[J].中国耳鼻咽喉头颈外科, 2024, 31(2): 122-124. DOI:10.16066/j.1672-7002.2024.02.012.

[15]郦海能,楼志平.咽鼓管球囊扩张术后不同诊断工具的临床评价[J].浙江临床医学, 2022, 24(8): 1156-1158.

[16]陈华侨.鼻腔冲洗联合普米克令舒雾化吸入治疗婴幼儿分泌性中耳炎的疗效观察[J].实用临床医药杂志, 2016, 20(15): 118-119. DOI:10.7619/jcmp.201615040.

[17]李谊,胡浩磊,邢培梅.耳内镜下经鼓室口行咽鼓管球囊扩张治疗伴有慢性化脓性中耳炎的延迟开放型咽鼓管功能障碍的临床研究[J].中国内镜杂志, 2023, 29(2): 82-88. DOI:10.12235/E20220164.

[18]Zasadzińska-Stempniak K, Karwat B, Jarmołowicz-Aniołkowska N, et al. Resolution of otitis media with effusion in adults after a three-day course of treatment with a manosonic nebulizer—a pilot study[J]. Medicina, 2023, 59(2): 201. DOI: 10.3390/medicina59020201.

[19]张晨,徐聪,郑凡君,等.同期咽鼓管球囊扩张术在慢性化脓性中耳炎患者听力重建中的应用[J].临床耳鼻咽喉头颈外科杂志, 2020, 34(10): 892-895. DOI:10.13201/j.issn.2096-7993.2020.10.007.

[20]陈祖鸿,蔡章,黄冬冬.地塞米松磷酸钠联合咽鼓管球囊扩张术治疗难治性分泌性中耳炎临床价值研究[J].陕西医学杂志, 2025, 54(2): 234-238,243. DOI:10.3969/j.issn.1000-7377.2025.02.019.

[21]Wong MSL, Prepageran N. Preliminary results of a pilot study on the safety and efficacy of balloon dilatation of the Eustachian tube for nasopharyngeal cancer patients with chronic Eustachian tube dysfunction post irradiation[J]. J Laryngol Otol, 2021, 135(8): 691-694. DOI:10.1017/S0022215121001560

[22]Krogshede SK, Kirchmann M, Jørkov APS, et al. Balloon dilation of the eustachian tube: a randomized controlled trial with 6 months follow-up[J]. J Int Adv Oto, 2022, 18(6): 501. DOI: 10.5152/iao.2022.21198.

[23]周锐,李佳,孙杰,等.氨溴索静脉注射联合雾化吸入对呼吸道黏膜上皮纤毛形态与功能的影响[J].重庆医学, 2022, 51(9): 1545-1548,1553. DOI:10.3969/j.issn.1671-8348.2022.09.022.

[24]Ai M, Liu X, Lin Y, et al. Efficacy of balloon Eustachian tuboplasty plus tympanostomy tube insertion in postirradiation otitis media with effusion[J]. Am J Otolaryngo, 2024, 45(4): 104301. DOI: 10.1016/j.amjoto.2024.104301.

[25]杨小颖,龚继涛.鼓膜穿刺联合布地奈德雾化治疗分泌性中耳炎疗效及相关影响因素研究[J].贵州医药, 2022, 46(7): 1091-1093. DOI:10.3969/j.issn.1000-744X.2022.07.045.